Nicole Levin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicole Levin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alex R. Ghorishi
Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA
1 shared publication Ann Lin
Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida
1 shared publication- Eric Eisner
Orthopedic Surgery, Memorial Healthcare, Hollywood, USA
1 shared publication - Fabio Stefano Frech
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA
1 shared publication Isabella Dreyfuss
Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine Fort Lauderdale Florida USA
1 shared publicationJames Grichnik
Department of Dermatology and Cutaneous Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida
1 shared publication
Latest Publications
- Open Access
- 30 July 2023
- Published by Elsevier in JAAD International
- Vol. 13, 172-178
Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- 30 July 2023
- Published by Elsevier in JAAD International
- Vol. 13, 172-178
Open AccessTreatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Open Access
- 22 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24380
Pathologic Fracture as Presentation of Generalized Lymphangiomatosis in an Eight-Year-Old: A Case Report and Literature Review
Pathologic fractures commonly occur secondary to abnormal skeletal physiology in the context of benign or malignant lesions. Rarely, pathologic fractures may occur in the context of a lymphatic abnormality, such as generalized lymphangiomatosis. This rare disorder is characterized by variable presentations in a broad age range of patients. By understanding the effect of widespread lymphatic anomalies on various organ systems, clinicians will be able to make this diagnosis earlier and with more certainty.
- 22 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24380
Open AccessPathologic Fracture as Presentation of Generalized Lymphangiomatosis in an Eight-Year-Old: A Case Report and Literature Review
Pathologic fractures commonly occur secondary to abnormal skeletal physiology in the context of benign or malignant lesions. Rarely, pathologic fractures may occur in the context of a lymphatic abnormality, such as generalized lymphangiomatosis. This rare disorder is characterized by variable presentations in a broad age range of patients. By understanding the effect of widespread lymphatic anomalies on various organ systems, clinicians will be able to make this diagnosis earlier and with more certainty.
- Open Access
- 12 April 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (6) , e15501
Basal cell carcinoma: An updated review of pathogenesis and treatment options
Basal cell carcinoma (BCC) remains the most common malignancy worldwide. BCC pathogenesis is a result of the interplay between one's environment, genetics, and phenotypic factors. BCC has a low mortality but given its increasing incidence and potential to cause local destruction thus resulting in significant morbidity, it is vital for dermatologists to remain up to date with recent updates in this malignancy's pathogenesis and treatment. This article provides a comprehensive review of the pathogenesis of BCC as well as the current treatments available and clinical trials underway. We also touch upon the updated National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology in respect to BCC's recommended treatment modalities.
- 12 April 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (6) , e15501
Open AccessBasal cell carcinoma: An updated review of pathogenesis and treatment options
Basal cell carcinoma (BCC) remains the most common malignancy worldwide. BCC pathogenesis is a result of the interplay between one's environment, genetics, and phenotypic factors. BCC has a low mortality but given its increasing incidence and potential to cause local destruction thus resulting in significant morbidity, it is vital for dermatologists to remain up to date with recent updates in this malignancy's pathogenesis and treatment. This article provides a comprehensive review of the pathogenesis of BCC as well as the current treatments available and clinical trials underway. We also touch upon the updated National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology in respect to BCC's recommended treatment modalities.